CAMBRIDGE, Mass., June 15, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced the election of John M. Dineen to its Board of Directors. Dineen, the former Chief Executive Officer of GE Healthcare, currently serves as an Operating Advisor to Clayton, Dublier & Rice, LLC.